中文

科伦药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥4.26B-3.0%
Gross profit¥1.93B
Operating income¥0.36B
Net income¥0.47B-28.3%
Gross margin45.3%Net margin 11.1%
Revenue Q/Q-18.7%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥2.33B54.7%
R&D¥0.59B13.8%
SG&A¥0.99B23.3%
Tax & other¥-0.12B-2.7%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

赣锋锂业沪电股份天齐锂业立讯精密荣盛石化天山铝业巨人网络比亚迪领益智造世纪华通光启技术卫星化学

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies